Irecently laid out a bullish thesis for Gilead Sciences (GILD) , and that trade just expired on Friday with a 144% gain. The bullish debit vertical spread successfully captured the upside to a new 52-week high as sentiment improved around Gilead's strengthening HIV franchise and expanding oncology portfolio. I'm looking to roll our profits into a new bullish position to capitalize on this momentum and position for what could evolve into a "home run" trade if the bullish trend persists for GILD. Trade timing & outlook Breakout confirmation: The breakout above the major $120 resistance signals the start of a new bullish trend. Momentum: GILD is now consolidating above prior resistance, setting the stage for an extended rally toward our $150 target. Relative strength: GILD continues to outper

See Full Page